Society for maternal-fetal medicine (SMFM) clinical guideline #7: Nonimmune hydrops fetalis

American Journal of Obstetrics and Gynecology

Volumn 212, Issue 2, 2015, Pages 127-139

  Norton, Mary E ^a,b   Chauhan, Suneet P ^c   Dashe, Jodi S ^d  

^a Society for Maternal Fetal Medicine Publications Committee   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

fetal complications; hydrops; nonimmune hydrops fetalis

Indexed keywords

CORTICOSTEROID;

ALLOIMMUNIZATION; ANEUPLOIDY; COCHRANE LIBRARY; COOMBS TEST; CRITICALLY ILL PATIENT; ECHOCARDIOGRAPHY; EMBASE; EVIDENCE BASED PRACTICE; FETUS HYDROPS; GESTATIONAL AGE; GYNECOLOGIST; HUMAN; MEDLINE; MICROARRAY ANALYSIS; MIDDLE CEREBRAL ARTERY; NATIONAL HEALTH ORGANIZATION; NEWBORN MORTALITY; NONIMMUNE HYDROPS FETALIS; PRACTICE GUIDELINE; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; ANEMIA; ARRHYTHMIAS, CARDIAC; COMPLICATION; DELIVERY; DOPPLER FLOWMETRY; DRAINAGE; FEMALE; FETAL DISEASES; FETUS ECHOGRAPHY; HYDROPS FETALIS; HYDROTHORAX; INTRAUTERINE BLOOD TRANSFUSION; PREGNANCY; PROCEDURES;

ANEMIA; ARRHYTHMIAS, CARDIAC; BLOOD TRANSFUSION, INTRAUTERINE; COOMBS TEST; DELIVERY, OBSTETRIC; DRAINAGE; ECHOCARDIOGRAPHY; FEMALE; FETAL DISEASES; HUMANS; HYDROPS FETALIS; HYDROTHORAX; PREGNANCY; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL;

EID: 84921636218     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.12.018     Document Type: Article

References (96)

1. M.A. Skoll, G.K. Sharland, and L.D. Allan Is the ultrasound definition of fluid collections in non-immune hydrops fetalis helpful in defining the underlying cause or predicting outcome? Ultrasound Obstet Gynecol 1 1991 309 312 (Level II-2)
2. A.J. Lee, M. Bethune, and R.J. Hiscock Placental thickness in the second trimester: a pilot study to determine the normal range J Ultrasound Med 31 2012 213 218 (Level II-3)
3. W.K. Hoddick, B.S. Mahony, P.W. Callen, and R.A. Filly Placental thickness J Ultrasound Med 4 1985 479 482 (Level II-3)
4. J. Santolaya, D. Alley, R. Jaffe, and S.L. Warsof Antenatal classification of hydrops fetalis Obstet Gynecol 79 1992 256 259 (Level III)
5. S. Heinonen, M. Ryynänen, and P. Kirkinen Etiology and outcome of second trimester non-immunologic fetal hydrops Acta Obstet Gynecol Scand 79 2000 15 18 (Level II-2)
6. G.A. Machin Hydrops revisited: literature review of 1,414 cases published in the 1980s Am J Med Genet 34 1989 366 390 (Level III)
7. A.A. Hutchison, J.H. Drew, V.Y. Yu, M.L. Williams, D.W. Fortune, and N.A. Beischer Nonimmunologic hydrops fetalis: a review of 61 cases Obstet Gynecol 59 1982 347 352 (Level III)
8. C. Bellini, and R.C. Hennekam Non-immune hydrops fetalis: a short review of etiology and pathophysiology Am J Med Genet A 158A 2012 597 605 (Level III)
9. C.A. Wy, C.H. Sajous, F. Loberiza, and M.G. Weiss Outcome of infants with a diagnosis of hydrops fetalis in the 1990s Am J Perinatol 16 1999 561 567 (Level III)
10. J.C. Larroche, M.C. Aubry, and F. Narcy Intrauterine brain damage in nonimmune hydrops fetalis Biol Neonate 61 1992 273 280 (Level III)
11. G.G. Laneri, D.L. Classen, and M.S. Scher Brain lesions of fetal onset in encephalopathic infants with nonimmune hydrops fetalis Pediatr Neurol 11 1994 18 22 (Level III)
12. S. Santo, S. Mansour, and B. Thilaganathan Prenatal diagnosis of non-immune hydrops fetalis: what do we tell the parents? Prenat Diagn 31 2011 186 195 (Level II-2)
13. C. Bellini, R.C. Hennekam, and E. Fulcheri Etiology of nonimmune hydrops fetalis: a systematic review Am J Med Genet A 149A 2009 844 851 (Level I)
14. M.E. Abrams, K.S. Meredith, P. Kinnard, and R.H. Clark Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death Pediatrics 120 2007 84 89 (Level II-2)
15. A.V. Lallemand, M. Doco-Fenzy, and D.A. Gaillard Investigation of nonimmune hydrops fetalis: multidisciplinary studies are necessary for diagnosis-review of 94 cases Pediatr Dev Pathol 2 1999 432 439 (Level III)
16. E. Jauniaux, L. Van Maldergem, C. De Munter, G. Moscoso, and Y. Gillerot Nonimmune hydrops fetalis associated with genetic abnormalities Obstet Gynecol 75 1990 568 572 (Level II-3)
17. V. Fesslova, L. Villa, S. Nava, C. Boschetto, C. Redaelli, and S. Mannarino Spectrum and outcome of atrioventricular septal defect in fetal life Cardiol Young 12 2002 18 26 (Level II-2)
18. C. Hofstaetter, M. Hansmann, S.H. Eik-Nes, J.C. Huhta, and S.L. Luther A cardiovascular profile score in the surveillance of fetal hydrops J Matern Fetal Neonatal Med 19 2006 407 413 (Level II-2)
19. A.L. Randenberg Nonimmune hydrops fetalis part II: does etiology influence mortality? Neonatal Netw 29 2010 367 380 (Level III)
20. S. Moodley, S. Sanatani, J.E. Potts, and G.G. Sandor Postnatal outcome in patients with fetal tachycardia Pediatr Cardiol 34 2013 81 87 (Level II-2)
21. M.T. Donofrio, A.J. Moon-Grady, and L.K. Hornberger American Heart Association Adults with Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council on Cardiovascular and Stroke Nursing. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association Circulation 129 2014 2183 2242 (Level III)
22. D.M. Friedman, M.Y. Kim, J.A. Copel, C. Hanos, C. Davis, and J.P. Beyon Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) study Am J Cardiol 103 2009 1102 1106 (Level II-1)
23. A. Alpman, O. Cogulu, and M. Akgul Prenatally diagnosed Turner syndrome and cystic hygroma: incidence and reasons for referrals Fetal Diagn Ther 25 2009 58 61 (Level II-2)
24. Y.E. Sükür, M. Gözüküçük, V. Bayramov, and A. Koç Fetal hydrops and anemia as signs of Down syndrome J Formos Med Assoc 110 2011 716 718 (Level III)
25. A. Akdag, B. Tunç, S. Oʇuz, D. Dilli, and U. Dilmen A newborn with Down syndrome-transient myeloproliferative disorder J Perinat Med 38 2010 445 447 (Level III)
26. A. Acar, O. Balci, and K. Gezginc Evaluation of the results of cordocentesis Taiwan J Obstet Gynecol 46 2007 405 409 (Level II-2)
27. G.L. Malin, M.D. Kilby, and M. Velangi Transient abnormal myelopoiesis associated with Down syndrome presenting as severe hydrops fetalis: a case report Fetal Diagn Ther 27 2010 171 173 (Level III)
28. S. Hojo, K. Tsukimori, and S. Kitade Prenatal sonographic findings and hematological abnormalities in fetuses with transient abnormal myelopoiesis with Down syndrome Prenat Diagn 27 2007 507 511 (Level II-2)
29. C. Liao, J. Wei, Q. Li, J. Li, L. Li, and D. Li Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in Southern China Fetal Diagn Ther 22 2007 302 305 (Level II-2)
30. C. Suwanrath-Kengpol, O. Kor-anantakul, T. Suntharasaj, and R. Leetanaporn Etiology and outcome of non-immune hydrops fetalis in southern Thailand Gynecol Obstet Invest 59 2005 134 137 (Level II-2)
31. Origa R, Moi P, Galanello R, Cao A. Alpha-Thalassemia. Nov. 1, 2005 (updated Nov 21, 2013). In: Pagon RA, Adam MP, Ardinger H, et al, eds. Seattle, WA: University of Washington, Seattle; 1993-2014. (Level III).
32. G.P. Giacoia Severe fetomaternal hemorrhage: a review Obstet Gynecol Surv 52 1997 372 380 (Level III)
33. M. Ahmed, and M. Abdullatif Fetomaternal transfusion as a cause of severe fetal anemia causing early neonatal death: a case report Oman Med J 26 2011 444 446 (Level III)
34. B.J. Wylie, and M.E. D'Alton Fetomaternal hemorrhage Obstet Gynecol 115 2010 1039 1051 (Level III)
35. C. Rubod, V. Houfflin, and F. Belot Successful in utero treatment of chronic and massive fetomaternal hemorrhage with fetal hydrops Fetal Diagn Ther 21 2006 410 413 (Level III)
36. Y. Tannirandorn, U. Nicolini, P. Nicolaidis, H. Nasrat, E.A. Letsky, and C.H. Rodeck Intrauterine death due to fetomaternal hemorrhage despite successful treatment of fetal anemia J Perinat Med 18 1990 233 235 (Level III)
37. P. Masson, A. Rigot, and W. Cécile Hydrops fetalis and G-6-PD deficiency Arch Pediatr 2 1995 541 544 (Level III)
38. P. Ferreira, L. Morais, and R. Costa Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency Eur J Pediatr 159 2000 481 482 (Level III)
39. A. Goncé, M.A. Marcos, and A. Borrell Maternal IgM antibody status in confirmed fetal cytomegalovirus infection detected by sonographic signs Prenat Diagn 32 2012 817 821 (Level II-3)
40. G. Syridou, N. Spanakis, and A. Konstantinidou Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings J Med Virol 80 2008 1776 1782 (Level II-2)
41. G. Carles, S. Lochet, and M. Youssef Syphilis and pregnancy J Gynecol Obstet Biol Reprod (Paris) 37 2008 353 357 (Level II-2)
42. M. Al-Buhtori, L. Moore, E.W. Benbow, and R.J. Cooper Viral detection in hydrops fetalis, spontaneous abortion, and unexplained fetal death in utero J Med Virol 83 2011 679 684 (Level II-2)
43. K. Tanimura, N. Kojima, T. Yamazaki, S. Semba, H. Yokozaki, and H. Yamada Second trimester fetal death caused by varicella-zoster virus infection J Med Virol 85 2013 935 938 (Level III)
44. C. Dubois-Lebbe, V. Houfflin-Debarge, A. Dewilde, L. Devisme, and D. Subtil Nonimmune hydrops fetalis due to herpes simplex virus type 1 Prenat Diagn 27 2007 188 189 (Level III)
45. N. Bachmaier, C. Fusch, R.D. Stenger, D. Grabow, R. Mentel, and R. Warzok Nonimmune hydrops fetalis due to enterovirus infection Eur J Obstet Gynecol Reprod Biol 142 2009 83 84 (Level III)
46. C.E. Oyer, E.H. Ongcapin, J. Ni, N.E. Bowles, and J.A. Towbin Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction Hum Pathol 31 2000 1433 1435 (Level III)
47. J.L. Anderson, P.T. Levy, K.B. Leonard, C.D. Smyser, L. Tychsen, and F.S. Cole Congenital lymphocytic choriomeningitis virus: when to consider the diagnosis J Child Neurol 29 2013 837 842 (Level III)
48. N. Young, M. Harrison, J. Moore, P. Mortimer, and R.K. Humphries Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro J Clin Invest 74 1984 2024 2032 (Level III)
49. H. Chisaka, E. Morita, N. Yaegashi, and K. Sugamura Parvovirus B19 and the pathogenesis of anemia Rev Med Virol 13 2003 347 359 (Level III)
50. M. Enders, K. Klingel, and A. Weidner Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection J Clin Virol 49 2010 163 168 (Level II-2)
51. M. Enders, A. Weidner, I. Zoellner, K. Searle, and G. Enders Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases Prenat Diagn 24 2004 513 518 (Level II-2)
52. N. Yaegashi, T. Niinuma, and H. Chisaka The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis J Infect 37 1998 28 35 (Meta-analysis)
53. R.F. Lamont, J.D. Sobel, and E. Vaisbuch Parvovirus B19 infection in human pregnancy BJOG 118 2011 175 186 (Level III)
54. Centers for Disease Control (CDC) Risks associated with human parvovirus B19 infection MMWR Morb Mortal Wkly Rep 38 1989 81 88 93-7. (Level III)
55. E. Miller, C.K. Fairley, B.J. Cohen, and C. Seng Immediate and long term outcome of human parvovirus B19 infection in pregnancy Br J Obstet Gynaecol 105 1998 174 178 (Level II-2)
56. A.C. Dijkmans, E.P. de Jong, and B.A. Dijkmans Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications Curr Opin Obstet Gynecol 24 2012 95 101 (Level III)
57. P. Cavoretto, F. Molina, S. Poggi, M. Davenport, and K.H. Nicolaides Prenatal diagnosis and outcome of echogenic fetal lung lesions Ultrasound Obstet Gynecol 32 2008 769 783 (Level II-2)
58. R.D. Wilson, J.K. Baxter, and M.P. Johnson Thoracoamniotic shunts: fetal treatment of pleural effusions and congenital cystic adenomatoid malformations Fetal Diagn Ther 19 2004 413 420 (Level II-2)
59. S. Schrey, E.N. Kelly, and J.C. Langer Fetal thoracoamniotic shunting for large macrocystic congenital cystic adenomatoid malformations of the lung Ultrasound Obstet Gynecol 39 2012 515 520 (Level II-2)
60. K.C. Loh, E. Jelin, S. Hirose, V. Feldstein, R. Goldstein, and H. Lee Microcystic congenital pulmonary airway malformation with hydrops fetalis: steroids vs open fetal resection J Pediatr Surg 47 2012 36 39 (Level II-2)
61. Y. Yinon, S. Grisaru-Granovsky, and V. Chaddha Perinatal outcome following fetal chest shunt insertion for pleural effusion Ultrasound Obstet Gynecol 36 2010 58 64 (Level II-2)
62. J.P. Van Den Wijngaard, M.G. Ross, and M.J. Van Gemert Twin-twin transfusion syndrome modeling Ann N Y Acad Sci 1101 2007 215 234 (Level III)
63. Society for Maternal-Fetal Medicine L.L. Simpson Twin-twin transfusion syndrome Am J Obstet Gynecol 208 2013 3 18 (Level III)
64. H. Lee, M. Bebbington, T.M. Crombleholme North American Fetal Therapy Network The North American Fetal Therapy Network Registry data on outcomes of radiofrequency ablation for twin-reversed arterial perfusion sequence Fetal Diagn Ther 33 2013 224 229 (Level II-2)
65. K. Overstreet, K. Benirschke, A. Scioscia, and E. Masliah Congenital nephrosis of the Finnish type: overview of placental pathology and literature review Pediatr Dev Pathol 5 2002 179 183 (Level III)
66. M. Zenker, T. Tralau, and T. Lennert Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: an autosomal recessive syndrome Am J Med Genet A 130A 2004 138 145 (Level III)
67. S. Noreen, D.S. Heller, and O. Faye-Petersen Mediastinal teratoma as a rare cause of hydrops fetalis and death: report of 3 cases J Reprod Med 53 2008 708 710 (Level III)
68. H. Isaacs Jr. Fetal hydrops associated with tumors Am J Perinatol 25 2008 43 68 (Level III)
69. T. Van Mieghem, A. Al-Ibrahim, and J. Deprest Minimally invasive therapy for fetal sacrococcygeal teratoma: case series and systematic review of the literature Ultrasound Obstet Gynecol 43 2014 611 619 (Level III)
70. H. Isaacs Perinatal (fetal and neonatal) tuberous sclerosis: a review Am J Perinatol 26 2009 755 760 (Level II-2)
71. M.C. McCoy, V.L. Katz, N. Gould, and J.A. Kuller Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management Obstet Gynecol 85 1995 578 582 (Level III)
72. A.M. Vintzileos, W.A. Campbell, P.J. Weinbaum, and D.J. Nochimson Perinatal management and outcome of fetal ventriculomegaly Obstet Gynecol 69 1987 5 11 (Level III)
73. B.P. Mathur, and S. Karan Non-immune hydrops fetalis due to osteopetrosis congenita Indian Pediatr 21 1984 651 653 (Level III)
74. C. Whybra, E. Mengel, and A. Russo Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature Orphanet J Rare Dis 7 2012 86 (Level III)
75. O. Staretz-Chacham, T.C. Lang, M.E. LaMarca, D. Krasnewich, and E. Sidransky Lysosomal storage disorders in the newborn Pediatrics 123 2009 1191 1207 (Level III)
76. A.C. Gimovsky, P. Luzi, and V. Berghella Lysomal storage diseases as an etiology of non-immune hydrops: a systematic review Am J Obstet Gynecol 2014 Oct 8 [Epub ahead of print] (Level I)
77. L. Gort, M.R. Granell, G. Fernández, P. Carreto, A. Sanchez, and M.J. Coll Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis Prenat Diagn 32 2012 1139 1142 (Level III)
78. P. Govaert, J.G. Leroy, and R. Pauwels Perinatal manifestations of maternal yellow nail syndrome Pediatrics 89 1992 1016 1018 (Level III)
79. G. Mari, R.L. Deter, and R.L. Carpenter Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization; Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses N Engl J Med 342 2000 9 14 (Level II-2)
80. V. Désilets, F. Audibert Society of Obstetrician and Gynecologists of Canada Investigation and management of non-immune fetal hydrops J Obstet Gynaecol Can 35 2013 923 938 (Level III)
81. T. Braun, M. Brauer, and I. Fuchs Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome Fetal Diagn Ther 27 2010 191 203 (Level III)
82. A. Gedikbasi, K. Oztarhan, and Z. Gunenc Preeclampsia due to fetal non-immune hydrops: mirror syndrome and review of literature Hypertens Pregnancy 30 2011 322 330 (Level III)
83. S. Goa, K. Mimura, and A. Kakigano Normalization of angiogenic imbalance after intra-uterine transfusion for mirror syndrome caused by parvovirus B19 Fetal Diagn Ther 34 2013 176 179 (Level III)
84. E. Llurba, G. Marsal, and O. Sanchez Angiogenic and antiangiogenic factors before and after resolution of maternal mirror syndrome Ultrasound Obstet Gynecol 40 2012 367 369 (Level III)
85. J.C. Livingston, K.M. Malik, T.M. Crombleholme, F.Y. Lim, and B.M. Sibai Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic shunt Obstet Gynecol 110 2007 540 543 (Level III)
86. D.Y. Midgley, and K. Hardrug The mirror syndrome Eur J Obstet Gynecol Reprod Biol 88 2000 201 202 (Level III)
87. R.S. Mascaretti, M.C. Falcão, A.M. Silva, F.A. Vaz, and C.R. Leone Characterization of newborns with non-immune hydrops fetalis admitted to a neonatal intensive care unit Rev Hosp Clin Fac Med Sao Paulo 58 2003 125 132 (Level III)
88. American College of Obstetricians and Gynecologists Management of preterm labor. ACOG Practice bulletin no. 127 Obstet Gynecol 119 2012 1308 1317 (Level III)
89. A.T. Sandlin, S.P. Chauhan, and E.F. Magann Clinical relevance of sonographically estimated amniotic fluid volume: polyhydramnios J Ultrasound Med 32 2013 851 863 (Level III)
90. H.R. Huang, P.K. Tsay, M.C. Chiang, R. Lien, and Y.H. Chou Prognostic factors and clinical features in liveborn neonates with hydrops fetalis Am J Perinatol 24 2007 33 38 (Level II-2)
91. C. Czernik, H. Proquitté, B. Metze, and C. Bührer Hydrops fetalis-has there been a change in diagnostic spectrum and mortality? J Matern Fetal Neonatal Med 24 2011 258 263 (Level II-2)
92. F. Bonvicini, C. Puccetti, and N.C. Salfi Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis J Clin Microbiol 49 2011 3514 3518 (Level II-3)
93. H.T. Nagel, T.R. de Haan, F.P. Vandenbussche, D. Oepkes, and F.J. Walther Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection Obstet Gynecol 109 2007 42 47 (Level III)
94. N.D. Hahurij, N.A. Blom, and E. Lopriore Perinatal management and long-term cardiac outcome in fetal arrhythmia Early Hum Dev 87 2011 83 87 (Level III)
95. American College of Obstetricians and Gynecologists Antepartum fetal surveillance. Practice bulletin no. 145 Obstet Gynecol 124 2014 182 192 (Level III)
96. J.H. Simpson, H. McDevitt, D. Young, and A.D. Cameron Severity of non-immune hydrops fetalis at birth continues to predict survival despite advances in perinatal care Fetal Diagn Ther 21 2006 380 382 (Level III)